San Diego company studies stem cell implant as a Type 1 diabetes treatment

Home/San Diego company studies stem cell implant as a Type 1 diabetes treatment

Los Angeles Times, Amber Dance, May 30, 2011: A pouch full of brand-new cells may one day reduce the need for people with Type 1 diabetes to take daily insulin shots. ViaCyte Inc. of San Diego has already used its technique to cure diabetes in hundreds of mice, says Eugene Brandon, one of the company’s directors. ViaCyte hopes to begin human trials of its implants, which are made from embryonic stem cells, by 2013, aided by $26 million in grants and loans from the California Institute of Regenerative Medicine, the state’s stem cell funding agency. Read entire article »

2014-05-29T16:58:07+00:00